Approvals/TGA/DBL SODIUM NITROPRUSSIDE CONCENTRATED INJECTION sodium nitroprusside 25 mg/mL concentrated injection vial

Approved

STANDARD

DBL SODIUM NITROPRUSSIDE CONCENTRATED INJECTION sodium nitroprusside 25 mg/mL concentrated injection vial

Pfizer Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 4f068f2c73349bb2
Product Name: DBL SODIUM NITROPRUSSIDE CONCENTRATED INJECTION sodium nitroprusside 25 mg/mL concentrated injection vial
Artg Id: 177111
Artg Name: DBL SODIUM NITROPRUSSIDE CONCENTRATED INJECTION sodium nitroprusside 25 mg/mL concentrated injection vial
Sponsor: Pfizer Australia Pty Ltd
Company Detail Path: /organization/pfizer-australia-pty-ltd
Artg Date: 2012-06-15
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/b06bf65b00e76374f6c5a6d8884174db.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/d384adff6040d66458da4b326d75dd10.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

4f068f2c73349bb2

Type

Standard